Bioequivalence and Bioavailability Forum 13:52 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Setup in Phoenix/WinNonlin [Study As­sess­ment]

posted by AngusMcLean - USA, 2016-05-16 21:00  - Posting: # 16317
Views: 13,079

» With Smith’s Cmax-data of Table 1 I got for the slope:
» 0.7617 (90% CI: 0.6696, 0.8539), slightly different from the reported 0.7615 (0.679, 0.844).

I have repeated the above calculation in NCSS as desribed by Jerry: here are the results of Brian Smith's example.
                                     90.0%       90.0%
          Effect   Effect            Lower       Upper
Effect    Estimate Standard Prob     Conf. Limit Conf. Limit     Effect
Name      (Beta)   Error    Level    of Beta     of Beta     DF  No.
Intercept  1.9414  0.2496   0.000025 1.4849      2.3978      9.2 1
logDose    0.7617  0.0492   0.000005 0.6659      0.8576      5.9 2


The within subject variance was 0.0146 (the same as Phoenix).


Edit: Full quote removed, tabulators changed to spaces and BBcoded. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5 and #6! [Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,032 posts in 4,059 threads, 1,299 registered users;
online 13 (0 registered, 13 guests [including 9 identified bots]).

When a distinguished but elderly scientist states that
something is possible, he is almost certainly right.
When he states that something is impossible,
he is very probably wrong.    Arthur C. Clarke

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed